Pathstone Family Office, LLC Esperion Therapeutics, Inc. Transaction History

Pathstone Family Office, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$25.12 - $36.89 $226 - $332	-9 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$30.04 - $51.31 $1,952 - $3,335	-65 Reduced 87.84%	9 $0
Q1 2020 Jun 11, 2020	BUY	$27.44 - $73.84 $1,783 - $4,799	65 Added 722.22%	74 $2,000
Q1 2020 May 07, 2020	BUY	$27.44 - $73.84 $246 - $664	9 New	9 $284,000
Q2 2019 Aug 14, 2019	SELL	$40.1 - $52.33 $2,406 - $3,139	-60 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$36.99 - $59.11 $2,219 - $3,546	60 New	60 $3,000

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $171M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Pathstone Family Office, LLC with notifications on news.